Clinical Trial

Epidural Electrical Stimulation to Restore Hemodynamic Stability and Trunk Control in People With Spinal Cord Injury

Study acronym: HemON
Recruiting
View on ClinicalTrials.gov →
Summary
The HemON study aims to evaluate the safety and preliminary efficacy of ARC-IM Therapy (Epidural Electrical Stimulation) to improve hemodynamic management and trunk control in people with sub-acute or chronic spinal cord injury (\>= 1 month post injury) between C3 and T6 inclusive, who suffer from orthostatic hypotension.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2021-11-01; most recent amendment 2025-05-26.
Status change: Not Yet Recruiting → Recruiting 2022-05-02
Trial Details
NCT Number NCT05111093
Lead Sponsor Ecole Polytechnique Fédérale de Lausanne
Conditions Spinal Cord Injuries
Enrollment 20 participants
Start Date 2021-11-29
Primary Completion 2030-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-30